Drug class

Antifungal - Azoles Systemic

Systemic azole antifungals are synthetic antimycotic agents administered orally or parenterally to manage invasive, mucosal, and endemic fungal infections. Read more about Antifungal - Azoles Systemic

131 drugs in this class 79 manufacturers

Advertisement

Drugs in Antifungal - Azoles Systemic

Showing 127–131 of 131 drugs

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC · ORAL CANDIDIASIS ·+11
REMEDYREPACK, I

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC · ORAL CANDIDIASIS ·+11
RADHA PHARMACEU

POSACONAZOLE

ANTIFUNGALS-SYSTEMIC · PREVENTION OF DISSEMINATED CANDIDIASIS ·+2
ATLANTIC BIOLOG

VORICONAZOLE

ANTIFUNGALS-SYSTEMIC · DISSEMINATED CANDIDIASIS ·+6
PHARMACEU ASSOC

FLUCONAZOLE

ANTIFUNGALS-SYSTEMIC · ORAL CANDIDIASIS ·+11
HAWAII REPACK,
Filter & compare in the drug finder → Opens the drug finder with Antifungal - Azoles Systemic preselected. Add indication or manufacturer filters there.

About Antifungal - Azoles Systemic.

Systemic azole antifungals are synthetic antimycotic agents administered orally or parenterally to manage invasive, mucosal, and endemic fungal infections.

They exert their therapeutic effect by inhibiting the fungal cytochrome P450–dependent enzyme 14-alpha-demethylase, which blocks the conversion of lanosterol to ergosterol, thereby disrupting fungal cell membrane stability and inhibiting cellular growth.

Clinically, these agents—primarily triazoles such as fluconazole, itraconazole, voriconazole, and posaconazole—serve as essential therapies for systemic candidiasis, invasive aspergillosis, cryptococcal meningitis, and endemic mycoses including blastomycosis, histoplasmosis, and coccidioidomycosis, as well as for antifungal prophylaxis in immunocompromised hosts.